The objective of the study was to assess the impact of direct to consumer advertising of prescription drugs in the United States on Canadian prescribing rates for three heavily marketed drugs—etanercept, mometasone, and tegaserod. Original Source
While yoga is thought to reduce the risk of chronic non-communicable diseases such as diabetes, there are no studies on insulin sensitivity in long term practitioners of yoga. The researchers assessed insulin sensitivity and cardiac autonomic function in long term practitioners of yoga.
The Ranbaxy sale to Daiichi Sankyo could herald a new phase in the evolution of the Indain pharmaceutical industry. In order to cope in a world after the agreement on Trade-related Aspects of Intellectual Property Rights came into force, some of the larger Indian firms pursued the two strategies of …
The country's largest drug maker Ranbaxy Laboratories today announced the launch of bonista teriparatide injection used in the treatment of osteoporosis (thinning of bones) in collaboration with Hyderabad-based Virchow Biotech. Ranbaxy has become the first company in the world to launch this bio-generic product, the company said in a filing …
MP's small and medium drug manufacturers, which are mainly located in Indore and Pithampur, are crying themselves hoarse due to the huge business losses being incurred due to non clearance and non-approvals from the drug controller's department. The post of the drug controller has been lying vacant for the last …
In a move likely to influence future drug price regulation in the country, the National Pharmaceutical Pricing Authority (NPPA) has started a process to understand how other countries carry out this function. The authority has already studied the relevant regulatory systems in at least eight major countries. It has also …
Justice S Ravinder Bhat of the Delhi High Court is a hero to some. His decision last month to allow generic drug manufacturer Cipla to continue manufacturing its version of Roche's patented lung cancer drug erlotinib (sold as Tarceva in India) has made him the toast of public health activists …
Novartis India is up in arms against a two-month old decision of the National Pharmaceutical Pricing Authority (NPPA) to reduce the price of its flagship brand Voveran on public interest grounds. The annual sales of Voveran, the brand name for pain reliever medicine diclofenac, exceed Rs 100 crore and account …
Hundreds of Japanese people accidentally infected with hepatitis C between the 1970s and 1990s are to be awarded compensation from the government and the drug companies responsible. But thousands of others also affected by the scandal stand to get nothing.
Chief Minister Tarun Gogoi on Tuesday launched a new health scheme under which cancer patients in the State will be provided chemotherapy drugs free of cost. Speaking at a function held on the occasion at the Dr. B. Borooah Cancer Institute here, Mr. Gogoi said the government decided to provide …
DEBATE Eventually, the debate boils down to whether removing patent rights will lead to lower R&D; in diseases that are important for patients in developing economies. Ranjit Shahani Vice-Chairman & Managing Director, Novartis India Limited If people don't get a fair return in innovation, they won't invest in finding new …
In Africa, hard-hit by HIV, the proportion of TB drug-resistance is no less alarming. In former Soviet Union, almost half of all TB cases are resistant to at least one anti-TB drug -Bobby Ramakant This World Tuberculosis (TB) Day (24 March) is another opportunity for people of India to review …
Does putting full sets of clinical trial data in the public domain affect a company's commercial interest? It might. But does the public interest not outweigh this? Yes, because if the product is useless or harmful, there should be no commerce in it in the first place. The scientific study …
A Delhi High Court interim order given last week can totally alter the patent regime in the country for life-saving drugs. The court allowed Cipla to market Erlontinib , a medicine for lung cancer, though the Indian patent on the drug, Tarceva, is held by Roche of Switzerland. The court …
358 of 413 drug patent applications for the disease in India are from top multinationals. The recent legal reverses suffered by multinational majors Novartis and Roche over patents for cancer medicine could be the tip of a huge iceberg. A city-based policy research group has found that multinational drug firms …
A tuberculosis research expert today said the world urgently needs a new drug for TB to provide relief to the ailing patients. In a statement issued on the eve of the World TB Day, Dr Balganesh, head of research at AstraZeneca, said, "With new societal changes, impacting the immune system, …
All four districts of Tripura have become malaria drug resistant while the State Government has asked the Centre to provide help in combating vulnerability to the deadly disease. Replying to a calling attention in the State Assembly here today, State Health and Family Welfare Minister Tapan Chakraborty revealed that three …
Even as nearly 4,000 people in the city are detected with tuberculosis every year, the numbers of those also resistant to drugs has increased over the years. To tackle the increasing problem of multi drug resistant tuberculosis (MDR-TB), the state government on World TB Day (March 24) has decided to …
Pfizer Inc, the world's largest pharmaceutical company, will soon initiate programmes to develop drugs specific to diseases in developing countries, such as India, moving away from its history of focusing on ailments prevalent in the US and Europe. "Our drug development activities in future will include drugs specific to regional …
With global pharma companies waking up to technology outsourcing services as a tool to reduce the time to market of their R&D; harvest, Accenture is looking at expanding the scope and scale of its lifescience centre of excellence in India. Accenture's life science R&D; centre in Bangalore is its largest …
